Formulated the Medium-Term Management Plan 2029 “1K Project – SPRING Strategy -“. Promote new value creation domains (drug discovery, textiles, and agri) and pursue growth and strengthening of the financial base through M&A. Set targets of 72,000 million yen in net sales, 4,100 million yen in operating income, and EPS of 111 yen. Promote creation of medical foods through M&A.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2929","jir_company_name":"Pharma Foods International Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-16","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/2929-20261016-01.pdf","jir_short_summary":"Formulated the Medium-Term Management Plan 2029 \"1K Project - SPRING Strategy -\". Promote new value creation domains (drug discovery, textiles, and agri) and pursue growth and strengthening of the financial base through M&A. Set targets of 72,000 million yen in net sales, 4,100 million yen in operating income, and EPS of 111 yen. Promote creation of medical foods through M&A.","jir_summary":"### Framework of the Medium-Term Management Plan 2029\nFormulated the Medium-Term Management Plan 2029 \"1K Project - SPRING Strategy -\". Actively develop drug discovery, textiles, and agri as new businesses to become the next pillars. Stabilize and return the core businesses to positive operating cash flow to strengthen the financial base. Accelerate growth by leveraging continuous M&A.\n\n### Financial Targets and Outlook for New Value Creation\nThe targets for the fiscal year ending July 2029 are net sales of 72,000 million yen, operating income of 4,100 million yen, operating cash flow of 3,400 million yen, and EPS of 111 yen. Sales growth is assumed to expand through promotion of the 1K Project and utilization of M&A. Going forward, the company will simultaneously promote profitability improvement of existing businesses and expansion of new domains.","jir_financial_highlights":"Net Sales: 72,000 million yen (New plan value)\nOperating Income: 4,100 million yen (New plan value)\nOperating Cash Flow: 3,400 million yen (New plan value)\nEPS: 111 yen (New plan value)","jir_category":"","jir_hashtags":"#PharmaFoodsInternational, #MediumTermPlan, #SPRINGStrategy, #NewBusinessDevelopment","jir_key_figures":"Net sales target: 72,000 million yen\nOperating income target: 4,100 million yen\nEPS target: 111 yen","jir_meta_title":"Pharma Foods International Co., Ltd. Announces Medium-Term Management Plan 2029\uff5cAggressive New Business Development and Strengthening of Financial Base","jir_meta_description":"Pharma Foods International announces the Medium-Term Management Plan 2029 \"1K Project - SPRING Strategy -\". The plan strengthens growth areas in drug discovery, textiles, and agri, targets continuous growth through M&A and financial soundness, and sets goals of 72,000 million yen in sales, 4,100 million yen in operating income, and EPS of 111 yen.","jir_og_title":"Formulated Medium-Term Plan 2029\uff5cPharma Foods International","jir_og_description":"Pharma Foods International announces a medium-term plan to develop three new business pillars. Stabilizing the financial base and growth through M&A are key.","jir_og_image_url":"\/assets\/og\/company-business_update.jpg","jir_chart_data_collection":"[]","ir_related_company":57923,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"business_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-132189","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n